Quoin Pharmaceuticals Files 2024 10-K
Ticker: QNRX · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 10-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, pharmaceuticals
TL;DR
Quoin Pharma 2024 10-K is in. Full financials out.
AI Summary
Quoin Pharmaceuticals, Ltd. filed its 2024 10-K on March 13, 2025, reporting financial results for the fiscal year ending December 31, 2024. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is involved in the pharmaceutical preparations industry. Key financial figures and operational details for the period are outlined in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Quoin Pharmaceuticals' financial health and operational performance for the fiscal year 2024, including any significant changes or events.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Quoin Pharmaceuticals is subject to significant regulatory, research and development, and market risks inherent in the industry.
Key Numbers
- 8948164 — Total Assets (Reported for the fiscal year ending 2024-12-31)
- 987220 — Total Liabilities (Reported for the fiscal year ending 2024-12-31)
- 104000 — Research and Development Expense (Reported for the fiscal year ending 2024-12-31)
- 25000 — Related Party Transactions (Indicates potential related party activities)
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer of the 10-K
- Cellect Biotechnology Ltd. (company) — Former name of Quoin Pharmaceuticals
- Cellect Biomed Ltd. (company) — Former name of Quoin Pharmaceuticals
- 2024-12-31 (date) — Conformed period of report
- 2025-03-13 (date) — Filed as of date
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What were Quoin Pharmaceuticals' total assets as of December 31, 2024?
Quoin Pharmaceuticals reported total assets of $8,948,164 as of December 31, 2024.
What were the total liabilities for Quoin Pharmaceuticals at the end of fiscal year 2024?
The company's total liabilities were $987,220 for the fiscal year ending December 31, 2024.
How much did Quoin Pharmaceuticals spend on Research and Development in fiscal year 2024?
Research and Development expenses for fiscal year 2024 amounted to $104,000.
When was Quoin Pharmaceuticals formerly known as Cellect Biotechnology Ltd.?
The company changed its name from Cellect Biotechnology Ltd. on July 21, 2016.
What is the Standard Industrial Classification code for Quoin Pharmaceuticals?
Quoin Pharmaceuticals is classified under SIC code 2834, which pertains to Pharmaceutical Preparations.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).